These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 637497)
1. A new approach to the treatment of renal failure. Rosin RD Ann R Coll Surg Engl; 1978 Mar; 60(2):99-107. PubMed ID: 637497 [TBL] [Abstract][Full Text] [Related]
2. A new approach to the treatment of renal failure. Rosin RD Br J Surg; 1976 Oct; 63(10):747-53. PubMed ID: 990694 [TBL] [Abstract][Full Text] [Related]
4. ["Clinical clearance" and "weekly clearance" of urea in periodical hemodialytic treatment]. Ghezzi PM; Palanca R; Dutto A; Cento G Minerva Med; 1980 Oct; 71(39):2821-3. PubMed ID: 7432691 [TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
6. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function. Sardenberg C; Suassuna P; Andreoli MC; Watanabe R; Dalboni MA; Manfredi SR; dos Santos OP; Kallas EG; Draibe SA; Cendoroglo M Nephrol Dial Transplant; 2006 Jan; 21(1):160-5. PubMed ID: 16155068 [TBL] [Abstract][Full Text] [Related]
7. Immunopathological changes in a uraemic rat model for peritoneal dialysis. Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671 [TBL] [Abstract][Full Text] [Related]
8. Problems and solutions for artificial kidney. Vanholder R Technol Health Care; 2000; 8(6):373-9. PubMed ID: 11258583 [TBL] [Abstract][Full Text] [Related]
9. Increased whole blood chemiluminescence in patients with chronic renal failure independent of hemodialysis treatment. Rysz J; Potargowicz E; Banach M; Luczyńska M; Stolarek R; Białasiewicz P; Kasielski M; Ciałkowska-Rysz A; Nowak D Arch Immunol Ther Exp (Warsz); 2006; 54(5):347-55. PubMed ID: 17031465 [TBL] [Abstract][Full Text] [Related]
10. Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis. Mahajan S; Kalra OP; Asit KT; Ahuja G; Kalra V Ren Fail; 2005; 27(4):357-60. PubMed ID: 16060119 [TBL] [Abstract][Full Text] [Related]
11. An analysis of the effectiveness and benefits of peritoneal dialysis and haemodialysis using Nigerian made PD fluids. Arogundade FA; Ishola DA; Sanusi AA; Akinsola A Afr J Med Med Sci; 2005 Sep; 34(3):227-33. PubMed ID: 16749353 [TBL] [Abstract][Full Text] [Related]
12. Nephrectomy and peritoneal dialysis eliminates circulating renin and controls uraemia in the rat. Pedersen TF; Nielsen AH; Strandgaard S; Paulson OB J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):130-4. PubMed ID: 12228855 [TBL] [Abstract][Full Text] [Related]
13. Impairment of glutathione biosynthetic pathway in uraemia and dialysis. Alhamdani MS Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350 [TBL] [Abstract][Full Text] [Related]
14. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu. Steddon SJ; McIntyre CW; Schroeder NJ; Burrin JM; Cunningham J Nephrol Dial Transplant; 2004 Dec; 19(12):3078-83. PubMed ID: 15494357 [TBL] [Abstract][Full Text] [Related]
15. Treatment time, chronic inflammation, and hemodynamic stability: the overlooked parameters in hemodialysis quantification. Zsom L; Zsom M; Fulop T; Flessner MF Semin Dial; 2008; 21(5):395-400. PubMed ID: 18945325 [TBL] [Abstract][Full Text] [Related]